<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04832191</url>
  </required_header>
  <id_info>
    <org_study_id>CE-MRI&amp;CESM in breast lesions</org_study_id>
    <nct_id>NCT04832191</nct_id>
  </id_info>
  <brief_title>CE-MRI&amp;CESM in Solid Breast Lesions</brief_title>
  <official_title>1.3 Role of Contrast-enhanced Mammography and Dynamic Contrast-enhanced MRI in the Assessment of Solid Breast Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study aimed to assess the accuracy of CE-SM in comparison to contrast-enhanced breast MRI&#xD;
      in the evaluation of solid breast lesions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer is the most common cancer in women, responsible for 23% of cancer in females&#xD;
      worldwide (1).&#xD;
&#xD;
      Early detection and accurate diagnosis of breast cancer aims to reduce morbidity and&#xD;
      mortality and have essential role in management and improved prognosis of breast cancer (2).&#xD;
&#xD;
      Mammography has been established as the imaging modality for screening and early detection of&#xD;
      breast cancer; however, it is accused of having low sensitivity and specificity in women with&#xD;
      dense breasts (3).&#xD;
&#xD;
      Contrast-enhanced MRI considered the gold standard method for diagnosis of breast cancer;&#xD;
      but, it has many limitations as high cost, long examination time and limited availability&#xD;
      (4,5).&#xD;
&#xD;
      Contrast-enhanced spectral mammogram (CESM) is considered now a relatively new imaging&#xD;
      modality which can provide both anatomic and functional information of the breast lesion&#xD;
      similar to MRI (6).&#xD;
&#xD;
      CESM like contrast-enhanced MRI (CE-MRI) is used to detect angiogenesis of the lesion in the&#xD;
      mammography suite. It includes high- and low-energy images during a single compression after&#xD;
      contrast injection (7).&#xD;
&#xD;
      The advantage of CESM over MRI is that it is less expensive and easier to perform with&#xD;
      shorter examination time. Also, the higher sensitivity of MRI is plagued by numerous&#xD;
      false-positive foci of enhancement (8).&#xD;
&#xD;
      Also, CESM can replace MRI in case of patient contraindicating for MRI as patients with&#xD;
      pacemakers, aneurysm clips or metal implants, or severe claustrophobia (7).&#xD;
&#xD;
      So, our study aims to determine the value of CESM and answer the question of does CESM could&#xD;
      replace CE-MRI in diagnosing breast cancer? so,our study aimed to assess the accuracy of CESM&#xD;
      in comparison to contrast-enhanced breast MRI in the evaluation of solid breast lesions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>comparison between accuracy of CESM and CE-MRI in diagnosing breast cancer.</measure>
    <time_frame>baseline</time_frame>
    <description>Measurement of sensitivity, specificity and predictive values of CESM and CE-MRI in diagnosing breast cancer.</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Neoplasms</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CE-SM</intervention_name>
    <description>contrast enhanced spectral mammography &amp;contrast enhanced magnetic resonance imaging</description>
    <other_name>CE-MRI</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients presented clinically with solid breast lesions.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have previously undergone mammography (MG) and ultrasound and have a&#xD;
             solid (BIRADs III and more) breast lesion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cystic breast lesions&#xD;
&#xD;
          -  BIRADs I and II breast lesions(benign)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of allergic reaction to iodinated contrast agent&#xD;
&#xD;
          -  Renal insufficiency&#xD;
&#xD;
          -  Other contraindications to MRI include pacemaker, claustrophobia or metal prosthesis.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Basma Fawzy Mohamed, assistant lecturer</last_name>
    <phone>01146393169</phone>
    <email>bfawzy1@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hazem Abou Zaid Yousef, Assistant professor</last_name>
    <phone>01005075888</phone>
    <email>Bozaidhazz@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Zhu X, Huang JM, Zhang K, Xia LJ, Feng L, Yang P, Zhang MY, Xiao W, Lin HX, Yu YH. Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis. Clin Breast Cancer. 2018 Oct;18(5):e985-e995. doi: 10.1016/j.clbc.2018.06.003. Epub 2018 Jun 15.</citation>
    <PMID>29983379</PMID>
  </reference>
  <reference>
    <citation>Li L, Roth R, Germaine P, Ren S, Lee M, Hunter K, Tinney E, Liao L. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions. Diagn Interv Imaging. 2017 Feb;98(2):113-123. doi: 10.1016/j.diii.2016.08.013. Epub 2016 Sep 26.</citation>
    <PMID>27687829</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 2, 2021</study_first_submitted>
  <study_first_submitted_qc>April 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>April 2, 2021</last_update_submitted>
  <last_update_submitted_qc>April 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Basma Fawzy Mohamed Gad El-Rab</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>CE-SM /CE-MRI/solid breast lesions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

